PremiumCompany AnnouncementsImmuPharma Achieves Breakthrough in Autoimmune Treatment with P140 ImmuPharma Sees Major Voting Rights Shift with Lanstead Capital’s Increased Stake ImmuPharma PLC Secures £2.91 Million in Equity Fundraise PremiumCompany AnnouncementsImmuPharma Appoints New Auditor Crowe LLP Immupharma Announces Change in Major Shareholdings ImmuPharma Strengthens Financial Team with New Appointment PremiumCompany AnnouncementsImmuPharma Gains Full Support at AGM ImmuPharma Schedules AGM, Shares Annual Report ImmuPharma Announces Progress and Reduced Losses